Evidence map›Paper›PMID 36271008›Full record

ArticleScientific reports2022

Development and cross-national investigation of a model explaining participation in WHO-recommended and placebo behaviours to prevent COVID-19 infection.

Joanna Kłosowska, Elżbieta A Bajcar, Helena Bieniek, Justyna Brączyk, Mohsen Joshanloo, Katia Mattarozzi, Arianna Bagnis, Moa Pontén, Maria Lalouni, Andrew L Geers and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Joanna KłosowskaInstitute of Psychology, Jagiellonian University, ul. Ingardena 6, 30-060, Kraków, Poland. joanna.klosowska@uj.edu.pl.ORCID 0000-0002-2583-6870
Elżbieta A BajcarInstitute of Psychology, Jagiellonian University, ul. Ingardena 6, 30-060, Kraków, Poland.
Helena BieniekInstitute of Psychology, Jagiellonian University, ul. Ingardena 6, 30-060, Kraków, Poland.
Justyna BrączykInstitute of Psychology, Jagiellonian University, ul. Ingardena 6, 30-060, Kraków, Poland.
Mohsen JoshanlooDepartment of Psychology, Keimyung University, Daegu, Republic of Korea.
Katia MattarozziDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Arianna BagnisDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Moa PonténDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Maria LalouniDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Andrew L GeersDepartment of Psychology, University of Toledo, Toledo, USA.
Kelly S ClemensDepartment of Psychology, University of Toledo, Toledo, USA.
Joonha ParkNUCB Business School, Nagoya, Japan.
Gahee ChoiDepartment of Psychology, Keimyung University, Daegu, Republic of Korea.
Yun-Kyeung ChoiDepartment of Psychology, Keimyung University, Daegu, Republic of Korea.
Wookyoung JungDepartment of Psychology, Keimyung University, Daegu, Republic of Korea.
Eunjung SonDepartment of Psychology, Keimyung University, Daegu, Republic of Korea.
Hyae Young YoonDepartment of Psychology, Keimyung University, Daegu, Republic of Korea.
Przemysław BąbelInstitute of Psychology, Jagiellonian University, ul. Ingardena 6, 30-060, Kraków, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To protect themselves from COVID-19, people follow the recommendations of the authorities, but they also resort to placebos. To stop the virus, it is important to understand the factors underlying both types of preventive behaviour. This study examined whether our model (developed based on the Health Belief Model and the Transactional Model of Stress) can explain participation in WHO-recommended and placebo actions during the pandemic. Model was tested on a sample of 3346 participants from Italy, Japan, Poland, Korea, Sweden, and the US. It was broadly supported: objective risk and cues to action showed both direct and indirect (through perceived threat) associations with preventive behaviours. Moreover, locus of control, decision balance, health anxiety and preventive coping moderated these relationships. Numerous differences were also found between countries. We conclude that beliefs about control over health and perceived benefits of actions are critical to the development of interventions to improve adherence to recommendations.

Indexed as

COVID-19AnxietyHealth BehaviorHumansPandemicsWorld Health Organization

Identifiers

PMID36271008
PMCPMC9586969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.